Least developed countries vs Rwanda: Access to anti-retroviral drugs, male
Least developed countries
80.9%
in 2024
Rwanda
95.0%
in 2024
Least developed countries rank
2nd
Rwanda rank
4th
Access to anti-retroviral drugs, male over time
- Least developed countries
- Rwanda
How they compare
Rwanda currently reports 95.0% against 80.9% in Least developed countries, a difference of 14.1%.
That makes Rwanda's figure about 1.2 times Least developed countries's.
The two have swapped places 2 times across 25 shared years of data; in 2000 it was Rwanda ahead.
Least developed countries ranks 2nd and Rwanda ranks 4th of 19 groups.
Rwanda has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Least developed countries | Rwanda | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 5.7% | 10.4% | 4.7% | Rwanda |
| 2010s | 40.1% | 60.0% | 19.9% | Rwanda |
| 2020s | 73.4% | 90.0% | 16.6% | Rwanda |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Least developed countries or Rwanda?
- Rwanda, at 95.0% against 80.9% in Least developed countries as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Least developed countries and Rwanda?
- 14.1%, with Rwanda ahead.
- How many years of comparable data are there for Least developed countries and Rwanda?
- 25 years are reported by both, from 2000 to 2024.
- How do Least developed countries and Rwanda rank globally for access to anti-retroviral drugs, male?
- Least developed countries ranks 2nd and Rwanda ranks 4th of 19 groups.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.